JPRN-UMIN000020912
Completed
未知
Prospective randomized observer-blinded study comparing the analgesic efficacy of ultrasound-guided rectus sheath block to local anesthetic infiltration for laparoscopic percutaneous extraperitoneal closure - The efficacy of US-guided rectus sheath block for laparoscopic percutaneous extraperitoneal closure
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- laparoscopic inguinal hernia surgery of children performed under general anesthesia
- Sponsor
- Hokkaido University
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •ASA 3 or grater psychiatric illness use of analgesics allergy to ropivacaine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Reducing radiation exposure during InterStim lead placementOveractive bladder, fecal incontinenceNervous System DiseasesISRCTN37385347Metro Health Hospital40
Completed
Not Applicable
To see the effect of training in laparoscopy on the performance of surgery trainees in the operation theatreCTRI/2012/11/003113All India Institute of Medical Sciences20
Not yet recruiting
Phase 4
Patient undergoing total knee replacement surgery for postoperative analgesia comparing 0.125% Bupivacaine and 0.2% Ropivacaine infusion for adductor canal blockCTRI/2024/04/065671D Y Patil University School of Medicine and Hospital Nerul Navi Mumbai
Not yet recruiting
Not Applicable
comparison of time taken to reverse the action of neuromuscular relaxant used during general anesthesia by sugammadex a novel drug with neostigmine-glycopyrrolate which is time tested drugCTRI/2023/07/055309P. D. Hinduja National Hospital and Medical Research Centre
Active, not recruiting
Phase 1
Clinical trial MV-CHIK-205 is designed to investigate the safety, tolerability, and long-term immunogenicity of a novel vaccine designed to protect against chikungunya virus, a mosquito-borne pathogen causing chikungunya fever throughout tropical areas worldwide.The study is being conducted in healthy volunteers for the prophylaxis of chikungunya virus (CHIKV) infection.Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2018-000211-25-GBThemis Bioscience GmbH60